Not Dead Yet: Movie & Music to End ALS
September 16, 2013 - San Francisco, CA: Attend a very special screening of the multi award-winning documentary about the life and music of guitarist extraordinaire Jason Becker, “Jason Becker: Not Dead Yet,” along with live musical performances by internationally-known hard rock and heavy metal guest musicians, in a benefit “Not Dead Yet: Movie and Music to End ALS” for the Jason Becker Special Needs Trustand ALS Therapy Development Institute (ALS TDI), Thursday, September 19, 2013 at Bimbo’s 365 Club. Doors are at 6:30 p.m. with showtime at 7:00 p.m.
UPDATE - September 13, 2012: use discount code NOTDEADYET (one word, all caps) to get $20 off the $50 price of General Admission tickets.
In 1990, 20-year old guitarist extraordinaire Jason Becker, after already recording two full-length albums of his own, was selected to play guitar for David Lee Roth - a position previously held by two of the greatest guitarists ever; Steve Vai and Edward Van Halen. Jason went on to record DLR’s third solo album, A Little Ain’t Enough, released in April 1991, was voted Best New Talent by Guitar Magazine by April of the very same year, and was about to begin a world tour that would make him an international guitar superstar when Becker began to feel what he called a "lazy limp" in his left leg. Doctors who soon diagnosed him with Amyotrophic Lateral Sclerosis (ALS; Lou Gehrig's Disease) said, not only would never make music again, he wouldn’t live to see his 25th birthday. Over two decades later, now confined to a wheelchair and without the ability to move or speak, Jason – considered by many to be the ‘Stephen Hawking of music’ - is very much alive and making music via the computer he controls only with his eyes.
Join Jason Becker and musical friends in a very special celebration of his life and music, with musical performances during intermission and after the screening by Pearl Aday and her band, Pearl, featuring guitarist (and husband) Scott Ian of Anthrax, guitarist Jim Wilson of Mother Superior and Henry Rollins’ Rollins Band, bassist Joey Vera of Armored Saint and Fates Warning, the San Francisco Bay Area’s Forrest Day, and special guests.
UPDATE - September 13, 2013: Arion Salazar, former bassist with Third Eye Blind and now with XEB, Dave Lopez, guitarist with Flypside, and Chris Kontos, former drummer with Machine Head and Testament will be attending.
$50 General Admission tickets include a light dinner buffet (while supplies last) and $75 VIP tickets include the dinner buffet, as well as reserved seating, a signed event poster and a meet and greet with Jason Becker and all the participating musicians.
· What: Not Dead Yet: Movie and Music to End ALS made possible by a contribution from Cytokinetics
· When: Thursday, September 19, 2013, doors at 6:30 p.m. Showtime at 7:00 p.m.
Tickets: $50 GA and $75 VIP.
· Directions: Google Maps: http://goo.gl/maps/k4IMY
For more info about “Jason Becker: Not Dead Yet” and to watch a preview, please visit: http://www.jasonbeckermovie.com. For special discounted ticket offers to, and other announcements about, “Not Dead Yet: Movie and Music to End ALS,” please follow on Facebook at: https://www.facebook.com/JasonBeckerMovie - visit http://www.jasonbecker.com to hear and purchase Jason Becker’s music.
For more info or to arrange an interview with any of the participating musicians, please contact Christopher Buttner at 415-233-7350 or email: firstname.lastname@example.org
Cytokinetics is a clinical-stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions. Cytokinetics currently is studying tirasemtiv in a Phase IIb clinical trial for the potential treatment of amyotrophic lateral sclerosis. Additional information about Cytokinetics can be obtained at http://www.cytokinetics.com.
About ALS Therapy Development Institute (ALS TDI)
The mission of the ALS Therapy Development Institute (ALS TDI), http://www.als.net/is to develop effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS, Lou Gehrig's disease) for patients today. For more info, please contact Mike Shannon, Development Director, at email@example.com or call 415-694-0663